Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Aurora, CO
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Aurora, CO
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Miami, FL
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Gainesville, GA
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Gainesville, GA
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Chicago, IL
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Beach Grove, IN
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Beach Grove, IN
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
New Orleans, LA
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Boston, MA
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Ann Arbor, MI
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Mineola, NY
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Mineola, NY
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis
mi
from
Portland, OR
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative Site
mi
from
Blue Bell, PA
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative Site
mi
from
Blue Bell, PA
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Providence, RI
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Providence, RI
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Dallas, TX
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated:  1/2/2013
Novartis Investigative site
mi
from
Madison, WI
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Post US Approval Voluntary Registry Study to Determine Incidence of Hypocalcemia Post Reclast® Treatment in Patients With Paget's Disease After Institution of Educational Strategies to Improve Adherence to Calcium and Vitamin D Supplementation
Status: Enrolling
Updated: 1/2/2013
Novartis Investigative site
mi
from
Madison, WI
Click here to add this to my saved trials
Effect of Beta-Alanine on Heart Rate Response
The Effect of 28 Days of Beta-alanine Supplementation on the Physical Working Capacity at Heart Rate Threshold (PWCHRT)
Status: Enrolling
Updated:  1/7/2013
UNC Exercise and Sport Science
mi
from
Chapel Hill, NC
Effect of Beta-Alanine on Heart Rate Response
The Effect of 28 Days of Beta-alanine Supplementation on the Physical Working Capacity at Heart Rate Threshold (PWCHRT)
Status: Enrolling
Updated: 1/7/2013
UNC Exercise and Sport Science
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Tucson Medical Center
mi
from
Tucson, AZ
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Tucson Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
East Bay Perinatal Associates
mi
from
Oakland, CA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
East Bay Perinatal Associates
mi
from
Oakland, CA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Stanford University
mi
from
Stanford, CA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Perinatal Diagnostic Center
mi
from
Riverside, CA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Perinatal Diagnostic Center
mi
from
Riverside, CA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
University of California at San Diego
mi
from
San Diego, CA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
University of California at San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
California Pacific Medical Center
mi
from
San Francisco, CA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
California Pacific Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
University of California - San Francisco
mi
from
San Francisco, CA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
University of California - San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Christiana Care Health System
mi
from
Wilmington, DE
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Christiana Care Health System
mi
from
Wilmington, DE
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
NorthShore University Health System
mi
from
Evanston, IL
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
NorthShore University Health System
mi
from
Evanston, IL
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Norton Healthcare
mi
from
Louisville, KY
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Norton Healthcare
mi
from
Louisville, KY
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Minnesota Perinatal Associates
mi
from
Minneapolis, MN
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Minnesota Perinatal Associates
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
St. Peters University Medical Center
mi
from
New Brunswick, NJ
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
St. Peters University Medical Center
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Robert Wood Johnson School of Medicine
mi
from
New Brunswick, NJ
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Robert Wood Johnson School of Medicine
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Columbia University
mi
from
New York, NY
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Oregon Health Sciences University
mi
from
Portland, OR
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Oregon Health Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Abington Memorial Hospital
mi
from
Abington, PA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Women's Health Care Group of Pennsylvania
mi
from
Wynnewood, PA
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Women's Health Care Group of Pennsylvania
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated:  1/8/2013
Medical College of Wisconsin
mi
from
Milwaukee, WI
Non-invasive Chromosomal Examination of Trisomy Study
Non-invasive Chromosomal Examination of Trisomy
Status: Enrolling
Updated: 1/8/2013
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
1218.74.01032 Boehringer Ingelheim Investigational Site
mi
from
Hoover, AL
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
1218.74.01032 Boehringer Ingelheim Investigational Site
mi
from
Hoover, AL
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.164 Boehringer Ingelheim Investigational Site
mi
from
Pinson, AL
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.164 Boehringer Ingelheim Investigational Site
mi
from
Pinson, AL
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
205.452.01317 Boehringer Ingelheim Investigational Site
mi
from
Mesa, AZ
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
205.452.01317 Boehringer Ingelheim Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
1220.48.0008 Boehringer Ingelheim Investigational Site
mi
from
Bakersfield, CA
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
1220.48.0008 Boehringer Ingelheim Investigational Site
mi
from
Bakersfield, CA
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
1245.25.10103 Boehringer Ingelheim Investigational Site
mi
from
Encino, CA
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
1245.25.10103 Boehringer Ingelheim Investigational Site
mi
from
Encino, CA
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
1218.75.081 Boehringer Ingelheim Investigational Site
mi
from
Garden Grove, CA
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
1218.75.081 Boehringer Ingelheim Investigational Site
mi
from
Garden Grove, CA
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.171 Boehringer Ingelheim Investigational Site
mi
from
La Habra, CA
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.171 Boehringer Ingelheim Investigational Site
mi
from
La Habra, CA
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.161 Boehringer Ingelheim Investigational Site
mi
from
Anoka, MN
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.161 Boehringer Ingelheim Investigational Site
mi
from
Anoka, MN
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.179 Boehringer Ingelheim Investigational Site
mi
from
Elk River, MN
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.179 Boehringer Ingelheim Investigational Site
mi
from
Elk River, MN
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
205.452.01104 Boehringer Ingelheim Investigational Site
mi
from
Fridley, MN
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
205.452.01104 Boehringer Ingelheim Investigational Site
mi
from
Fridley, MN
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.165 Boehringer Ingelheim Investigational Site
mi
from
Roseville, MN
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.165 Boehringer Ingelheim Investigational Site
mi
from
Roseville, MN
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.166 Boehringer Ingelheim Investigational Site
mi
from
St. Francis, MN
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.166 Boehringer Ingelheim Investigational Site
mi
from
St. Francis, MN
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
Boehringer Ingelheim Investigational Site
mi
from
Albuquerque, NM
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
Boehringer Ingelheim Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
205.452.01274 Boehringer Ingelheim Investigational Site
mi
from
Longview, TX
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
205.452.01274 Boehringer Ingelheim Investigational Site
mi
from
Longview, TX
Click here to add this to my saved trials
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated:  1/8/2013
527.82.172 Boehringer Ingelheim Investigational Site
mi
from
Lufkin, TX
An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms
A 8-week, Open-label, Uncontrolled, Exploratory Actual Use Study of Tamsulosin 0.4mg in Men With Prostate Urinary Symptoms in a Simulated Over-the-Counter Environment
Status: Enrolling
Updated: 1/8/2013
527.82.172 Boehringer Ingelheim Investigational Site
mi
from
Lufkin, TX
Click here to add this to my saved trials